Medicine care team

Research Administrative Assistant: Tilley Creary
Fax: 416-480-6048
Email: tilley.creary@sunnybrook.ca

For media or interview inquiries, please contact Sunnybrook's Communications and Stakeholder Relations office: 416-480-4040. The 24-hour media contact number is 416-480-4244.

Education:

• B.Phm., 1990, pharmacy, Dalhousie University, Canada
• MD, 1994, Dalhousie University, Canada
• FRCPC, 1998, internal medicine, University of Toronto, Canada
• FRCPC, 2000, clinical pharmacology, U of T, Canada
• Fellowship, 2002, medical toxicology, U of T, Canada
• PhD, 2003, clinical epidemiology, U of T, Canada

Appointments and Affiliations:

• Scientist, Evaluative Clinical Sciences, Integrated Community Research Program, Sunnybrook Research Institute
• Senior scientist, Institute for Clinical Evaluative Sciences
• Professor, departments of medicine and pediatrics, U of T
• Staff physician, divisions of general internal medicine and clinical pharmacology, Sunnybrook Health Sciences Centre
• Medical toxicologist, Ontario Poison Information Centre, Hospital for Sick Children

Dr. Juurlink is a staff internist and head of the division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto. He is also a medical toxicologist at the Ontario Poison Centre at the Hospital for Sick Children and a scientist at the Institute for Clinical Evaluative Sciences. He received degrees in Pharmacy (1990) and Medicine (1994) from Dalhousie University in Halifax, Nova Scotia, and completed postgraduate training in Internal Medicine (1998) followed by residency in Clinical Pharmacology (2000), a fellowship in Medical Toxicology (2002), and a PhD in Clinical Epidemiology (2003), all at the University of Toronto. He has received certification from the American Board of Internal Medicine, the American Board of Emergency Medicine (Medical Toxicology), and the American Board of Clinical Pharmacology.

He is presently the Sunnybrook site director for the program in Clinical Pharmacology & Toxicology and is Chair of the Royal College of Physicians and Surgeons Examinations Committee in Clinical Pharmacology and Toxicology

In addition to his clinical, teaching, and administrative activities, Dr. Juurlink maintains an active research program in the field of drug safety. His areas of particular interest include drug safety, adverse drug events, the consequences of drug-drug interactions in clinical practice, the safety of prescription opioids, and the epidemiology of suicide and deliberate self-poisoning.